Uracil

DB03419InvestigationalSmall molecule

Uracil is an antineoplastic agent used in combination with tegafur to treat various cancers, including breast, prostate, and liver cancer.

Chemical structure of Uracil
Mechanism
Curator reviewed
Formula / weight
C4H4N2O2 · 112.0868 g/mol (avg)
Code names
BMS-205603-01 · NSC-3970 · SQ-6201

Resolves to

Compound
UNII56HH86ZVCTCAS66-22-8ChEMBLCHEMBL566ChEBI17568PubChem1174KEGGD00027
Clinical / RWD
RxNorm10995
Structure
InChIKeyISAKRJDGNUQOIC-UHFFFAOYSA-NSMILESO=C1NC=CC(=O)N1
Targets
Q12882DPYDQ9NWZ5UCKL1P10186Uracil-DNA glycosylaseQ8X444ungP0AA43rsuAQ5SKC5udgP77836pdp

What you can answer from here — as of September 23, 2026

7Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
32Drug interactionsStructured to mechanism, not free text
Sign in
12Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
4Marketed productsAcross 3 countries and 4 labellers
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Uracil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In